China's First SmartLOAD® Smart Preloaded Intraocular Lens Implantation Successfully Completed

GuangzhouMay 26, 2022PR Newswire -- On May 5, led by Professor Chen Weirong, Chair of the Ophthalmology Branch of the Guangdong Provincial Medical Association and a team from Zhongshan Ophthalmic Center of Sun Yat-sen University, the first case in China of Johnson & Johnson Vision's SmartLOAD was successfully performed.^®Intelligent Preloaded Intraocular Lens Implantation Surgery Marks the Official Application of This Product in the Chinese Market. The Introduction of This Innovative Product Will Bring Light to More Cataract Patients, Enriching Cataract Surgical Treatment Options and Further Promoting the Development of the Cataract Treatment Industry.

China's First Johnson & Johnson Vision SmartLOAD(R) Intelligent Preloaded Intraocular Lens Implant Surgery Completed at Zhongshan Ophthalmic Center, Sun Yat-sen University

Cataract, the leading cause of blindness globally, has an incidence rate as high as 80% among people aged 60 to 89 in China, severely affecting the vision and quality of life for elderly patients. Currently, surgery remains the only effective treatment for cataracts. This year, the "14th Five-Year" National Eye Health Plan (2021-2025) issued by China's National Health Commission clearly stated that by 2025, the Cataract Surgical Rate (CSR) should be increased to allow more patients to enjoy high-quality vision. Modern advanced cataract surgical instruments and equipment, high-quality intraocular lenses, and continuously improving ophthalmic surgical techniques will provide patients with excellent visual quality to meet their daily activity needs.

In order to better benefit cataract patients, Johnson & Johnson Vision introduced the preloaded intraocular lens implantation system in China in 2015. Compared with non-preloaded intraocular lens implantation, it offers shorter operation time, faster postoperative recovery, lower infection risk, fewer complications, and better visual quality. The SmartLOAD launched this time^®It is the first intelligent preloaded injection system, which has been comprehensively upgraded from the original preloaded intraocular lens implantation system.

SmartLOAD(R) Intelligent Preloaded Injection System

Professor Chen Weirong stated: "This intelligent preloaded injection system is firstly more streamlined in design compared to previous models, making our surgical operations more convenient. The significant reduction in surgery loading time can further prevent infections during the procedure and reduce the incidence of posterior capsule opacification (PCO) in patients after surgery. Moreover, since the lens is made of hydrophobic material, which is transparent and free of glare, it ensures good visual quality for patients post-surgery. In this first case, the patient's bilateral vision recovered to 0.8 and 0.6 within one to two days after the surgery." Notably, the product also greatly reduces the use of plastic in its material design, significantly cutting down on medical waste and promoting sustainable development.

Professor Chen Weirong, Director of the Ophthalmology Branch of the Guangdong Medical Association and Zhongshan Ophthalmic Center, Sun Yat-sen University, performs surgery on patients.

"As one of the global leaders in the eye health industry, Johnson & Johnson Vision is committed to promoting technological innovation and breakthroughs in the field of eye health and dedicated to providing high-quality eye health management solutions," said Mr. Wang Liping, Vice President of Johnson & Johnson Vision for Greater China, Australia, and New Zealand. "We hope these innovative professional medical products will better help a large number of patients improve and restore their eye health, enhance their quality of life, and contribute to the realization of the goals set out in China's '14th Five-Year Plan' for national eye health."

Johnson & Johnson Vision has always adhered to its firm belief in being deeply rooted in China, maintaining close cooperation with all parties to actively promote pioneering innovation and technological advancement in the field of eye health. It continuously introduces cutting-edge global technologies and innovative products to better meet the personalized and diverse eye health needs of patients in China. As these innovative technologies and products continue to be introduced and adapted, Johnson & Johnson Vision will continue to contribute to the rapid development of ophthalmic medical standards in China.